---
title: "Alto Neuroscience Launches $93.9M Stock Offering at $26.48 in BofA-Led Underwriting"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292605701.md"
description: "Alto Neuroscience launched a $93.9 million registered direct stock offering at $26.48 per share, led by BofA Securities. The company will issue 3,776,436 common shares, with proceeds allocated to accelerate clinical development of ALTO-207, including a Phase 3 trial, and for general working capital. The transaction is expected to close on July 14, 2026."
datetime: "2026-07-14T10:13:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292605701.md)
  - [en](https://longbridge.com/en/news/292605701.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292605701.md)
---

# Alto Neuroscience Launches $93.9M Stock Offering at $26.48 in BofA-Led Underwriting

Alto Neuroscience entered into an underwriting agreement to sell 3,776,436 shares of common stock at $26.48 per share in a registered direct offering. The company expects approximately $93.9 million in net proceeds, with closing anticipated on Jul 14, 2026, subject to customary conditions. The BofA Securities-led syndicate includes Stifel, William Blair, and Baird as joint bookrunners, with JonesTrading and H.C. Wainwright as co-managers. Proceeds will support accelerated clinical development of ALTO-207, including an additional planned Phase 3 trial, and general working capital.

**Agreement details:**

-   **Agreement type**: Underwriting agreement for registered direct common stock offering
-   **Counterparty**: BofA Securities, as representative of the underwriters
-   **Signed / Effective**: Jul 13 2026 / same
-   **Duration / Termination**: At will
-   **Reason**: Raise capital for ALTO-207 and working capital

Original SEC Filing: Alto Neuroscience, Inc. \[ ANRO \] - 8-K - Jul. 14, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ANRO.US](https://longbridge.com/en/quote/ANRO.US.md)
- [BAC.US](https://longbridge.com/en/quote/BAC.US.md)
- [SF.US](https://longbridge.com/en/quote/SF.US.md)
- [SF-C.US](https://longbridge.com/en/quote/SF-C.US.md)
- [SFB.US](https://longbridge.com/en/quote/SFB.US.md)
- [SF-B.US](https://longbridge.com/en/quote/SF-B.US.md)
- [SF-D.US](https://longbridge.com/en/quote/SF-D.US.md)

## Related News & Research

- [BofA, USAA agree to cross-license AI, banking patents](https://longbridge.com/en/news/294845787.md)
- [First Nebraska Trust Co Invests $471,000 in Bank of America Corporation $BAC](https://longbridge.com/en/news/294659130.md)
- [REG - Bank of America Corp - Publication of a Supplementary Prospectus](https://longbridge.com/en/news/294677341.md)
- [Bank of America Corporation $BAC Shares Sold by Blue Edge Capital LLC](https://longbridge.com/en/news/294598667.md)
- [VectorGlobal IAG Inc. Purchases New Position in Bank of America Corporation $BAC](https://longbridge.com/en/news/294678048.md)